The Merck (MRK) pill regimen looks like a solution to protecting people from [the worst of] Covid-19. But there will still be need for other medicines as well. While Merck stock has soared 7.8% in one day after the news, the plunge in prices of alternative treatments like Moderna, Novavax, and BioNTech has been excessive, because the Merck pill will not be available for everyone to take for months at best.
Our best performer last week was Merck, up 10.6% but a close second was Cabot Oil, COG, up 9.4% and Energy Fuels, UUUU, up 8.1%. Healthcare shares fell, even ones with little involvement with Covid-19 because they got ahead of themselves.
Comments
Log in or sign up to join the conversation.